ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,035.69
-1.57%
US Tech 100
16,918.80
-2.26%
다우존스 지수
37,815.92
-1.49%
Bitcoin
60,171.22
-0.71%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Rigel Pharmaceuticals Inc (RIGL)

  7. Rigel Pharmaceuticals Inc (RIGL) 뉴스

RIGL Rigel Pharmaceuticals Inc

1.04
-0.03 (-2.80%)
01 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Rigel Pharmaceuticals Inc RIGL 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
-0.03 -2.80% 1.04 08:53:45
개장가 저가 고가 종가 전일 종가
1.07 1.04 1.1096 1.05 1.07
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
30/04/202421:05PRNUSRigel Announces Conference Call and Webcast to Report First..
11/04/202405:30PRNUSRigel Announces Inducement Grants under NASDAQ Listing Rule..
04/04/202421:05PRNUSRigel Announces Publication of Data on REZLIDHIA®..
12/03/202421:05PRNUSRigel Pharmaceuticals Announces Appointment of Lisa..
06/03/202406:10EDGAR2Form 8-K - Current report
06/03/202406:06EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
06/03/202406:01PRNUSRigel Reports Fourth Quarter and Full Year 2023 Financial..
02/03/202409:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/03/202409:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/03/202409:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/03/202409:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/02/202422:05PRNUSRigel Announces Conference Call and Webcast to Report Fourth..
22/02/202422:00EDGAR2Form 8-K - Current report
22/02/202421:50PRNUSRigel Pharmaceuticals Acquires U.S. Rights to GAVRETO®
15/02/202404:30EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/02/202410:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/02/202410:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/02/202410:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/02/202423:56EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
26/01/202411:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/01/202411:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/01/202411:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/01/202411:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/01/202403:48EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/01/202422:30EDGAR2Form 8-K - Current report
08/01/202422:05PRNUSRigel Pharmaceuticals Provides Business Update
06/01/202406:30PRNUSRigel Announces Inducement Grants under NASDAQ Listing Rule..
04/01/202422:05PRNUSRigel Announces Collaboration with CONNECT to Conduct a..
03/01/202422:05PRNUSRigel to Present at the 42nd Annual J.P. Morgan Healthcare..
08/12/202322:05PRNUSRigel Pharmaceuticals and MD Anderson Announce Strategic..
30/11/202320:04EDGAR2Form 8-K - Current report
08/11/202306:16EDGAR2Form 8-K - Current report
08/11/202306:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202306:01PRNUSRigel Reports Third Quarter 2023 Financial Results and..
06/11/202322:05PRNUSRigel to Present at the Jefferies London Healthcare..
02/11/202322:27PRNUSRigel Announces Poster Presentations at the 65th American..
31/10/202321:05PRNUSRigel Announces Conference Call and Webcast to Report Third..
11/10/202321:05PRNUSRigel Announces Presentation at the Upcoming IDWeek 2023
07/10/202305:30PRNUSRigel Announces Inducement Grants under NASDAQ Listing Rule..
20/09/202321:05PRNUSRigel to Present at the 2023 Cantor Global Healthcare..
30/08/202321:05PRNUSRigel to Participate in Upcoming September Investor..
02/08/202305:31EDGAR2Form S-8 - Securities to be offered to employees in employee..
02/08/202305:15EDGAR2Form 8-K - Current report
02/08/202305:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/08/202305:01PRNUSRigel Reports Second Quarter 2023 Financial Results and..
25/07/202321:00PRNUSRigel Announces Conference Call and Webcast to Report Second..
13/07/202307:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/07/202307:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/07/202307:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/07/202307:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..

최근 히스토리

NASDAQ
RIGL
Rigel Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유